Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
D000328:Adult; D000368:Aged; D000641:Ammonia / Q000097:blood; D001927:Brain Diseases / Q000209:etiology; D004187:Disaccharides / Q000009:adverse effects / Q000627:therapeutic use*; D004569:Electroencephalography; D005243:Feces; D005260:Female; D006505:Hepatitis / Q000150:complications; D006801:Humans; D007200:Indican / Q000652:urine; D007211:Indoles / Q000097:blood; D008103:Liver Cirrhosis / Q000150:complications; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy*; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000188:drug therapy*; D011168:Portal System; D011594:Psychometrics
D004187:Disaccharides; D007211:Indoles; D008278:Magnesium Sulfate; D000641:Ammonia; D007200:Indican